About Anthony Zietman, MD

Dr Zietman received his undergraduate training at Oxford University in the UK and then went to medical school at the Middlesex Hospital, London University graduating in 1983. After residencies in internal medicine and clinical oncology he moved to the Massachusetts General Hospital in Boston, USA for a fellowship in radiation biology. Since joining the staff he has authored over 100 original articles and reviews on many aspects of GU cancer. His particular research interests are in the specific roles of active surveillance, brachytherapy, hormone therapy, and proton beam therapy in the treatment of prostate cancer. He also has a long-standing interest in the organ-sparing management of bladder cancer. He is currently the Jenot and William Shipley Professor of Radiation Oncology at Harvard Medical School, President of the American Society for Radiation Oncology (ASTRO), and a trustee of the American Board of Radiology.

Departments, Centers, & Programs:

Clinical Interests:




Mass General Cancer Center: Center for Genitourinary Cancers
55 Fruit St.
Boston, MA 02114
Phone: 617-726-5866

Mass General Cancer Center: Radiation Oncology
55 Fruit St.
Lunder Building, LL3
Boston, MA 02114
Phone: 617-726-5866

Medical Education

  • MD, University of London, School of Medicine/University College
  • Residency, Middlesex Hosp/England
  • Residency, Mt. Vernon Hospital
  • Residency, Westminster Hospital
  • Fellowship, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Radiation Oncology, American Board of Radiology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


  • Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A.L., O'Leary M, Walker-Corkery E, Yao SL. Outcomes of localized prostate cancer following conservative management. JAMA 16:302 1202-9 2009

    Zietman A.L., Bae K., Slater J.D., Shipley W.U., Efstathiou J.A., Coen J.J., Bush D.A., Lunt M., Spiegel D.Y., Skowronski R., Jabola B.R., Rossi C.J. A randomized trial comparing conventional dose conformal radiation therapy with high-dose in early stage adenocarcinoma of the prostate. Long-term results from Proton Radiaiton Oncology Group (PROG)/American College of Radiology (ACR) 95-09. J. Clin. Oncol. (in press) 2009.

    Zietman A.L.. The Titanic and The Iceberg: prostate proton therapy and healthcare economics. J. Clin. Oncol. 25: 3565-66, 2007.

    Zietman A.L.. Evidence-based medicine, conscience-based medicine, and the management of low-risk prostate cancer.J. Clin Oncol. 27:4935-6, 2009

Reviews: Comments and Ratings